Vir Biotechnology, Inc.
NASDAQ:VIR
9.87 (USD) • At close November 11, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 254.844 | 848.631 | 347.815 | 436.575 | 109.335 | 47.598 | 187.918 |
| Short Term Investments
| 1,280.833 | 1,553.409 | 360.33 | 300.286 | 274.101 | 50.845 | 0 |
| Cash and Short Term Investments
| 1,535.677 | 2,402.04 | 708.145 | 736.861 | 383.436 | 98.443 | 187.918 |
| Net Receivables
| 11.6 | 0 | 773.079 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 8.594 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 40.949 | 104.356 | 73.003 | 27.511 | 13.378 | 8.579 | 4.432 |
| Total Current Assets
| 1,588.226 | 2,519.077 | 1,562.821 | 772.365 | 402.995 | 117.783 | 192.35 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 167.2 | 188.166 | 130.054 | 79.893 | 16.308 | 12.29 | 5.138 |
| Goodwill
| 16.937 | 16.937 | 16.937 | 16.937 | 16.937 | 16.937 | 16.937 |
| Intangible Assets
| 22.592 | 32.755 | 33.287 | 33.82 | 35.694 | 36.917 | 35.882 |
| Goodwill and Intangible Assets
| 39.529 | 49.692 | 50.224 | 50.757 | 52.631 | 53.854 | 52.819 |
| Long Term Investments
| 111.723 | 23.927 | 201.388 | 12.619 | 24.29 | 7.669 | 1.003 |
| Tax Assets
| 41.03 | 249.724 | 96.854 | -12.619 | 0 | -7.669 | -1.003 |
| Other Non-Current Assets
| 12.382 | -228.498 | -87.073 | 15.746 | 15.847 | 7.669 | 1.259 |
| Total Non-Current Assets
| 371.864 | 283.011 | 391.447 | 146.396 | 109.076 | 73.813 | 59.216 |
| Total Assets
| 1,960.09 | 2,802.088 | 1,954.268 | 918.761 | 512.071 | 191.596 | 251.566 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 6.334 | 6.422 | 6.521 | 5.077 | 5.881 | 6.473 | 4.898 |
| Short Term Debt
| 12.867 | 4.137 | 3.927 | 3.89 | 0.237 | 14.534 | 0 |
| Tax Payables
| 0.149 | 15.228 | 6.217 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 64.853 | 15.517 | 98.209 | 6.451 | 6.181 | 8.761 | 0 |
| Other Current Liabilities
| 84.87 | 463.303 | 219.847 | 78.569 | 41.026 | 3.667 | 2.642 |
| Total Current Liabilities
| 175.407 | 511.029 | 341.242 | 99.064 | 59.206 | 39.908 | 12.438 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 111.673 | 123.837 | 133.561 | 66.556 | 0 | 310.161 | 293.454 |
| Deferred Revenue Non-Current
| 1.526 | 53.207 | 3.815 | 3.815 | 12.67 | 6.561 | 0.888 |
| Deferred Tax Liabilities Non-Current
| 43.22 | 3.253 | 18.439 | 3.253 | 3.305 | 3.305 | 3.305 |
| Other Non-Current Liabilities
| 38.028 | 32.799 | 25.362 | 29.221 | 12.948 | 10.838 | 10.397 |
| Total Non-Current Liabilities
| 194.447 | 213.096 | 181.177 | 102.845 | 28.923 | 330.865 | 308.044 |
| Total Liabilities
| 369.854 | 724.125 | 522.419 | 201.909 | 88.129 | 370.773 | 320.482 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 512.071 | 309.137 | 292.525 |
| Common Stock
| 0.013 | 0.013 | 0.013 | 0.013 | 0.011 | 0.001 | 0.001 |
| Retained Earnings
| -237.824 | 377.237 | -138.6 | -667.184 | -368.519 | -193.836 | -77.952 |
| Accumulated Other Comprehensive Income/Loss
| -0.815 | -9.122 | -1.099 | -1.278 | -0.601 | -0.014 | -292.525 |
| Other Total Stockholders Equity
| 1,828.862 | 1,709.835 | 1,571.535 | 1,385.301 | 280.98 | -294.465 | 9.035 |
| Total Shareholders Equity
| 1,590.236 | 2,077.963 | 1,431.849 | 716.852 | 423.942 | -179.177 | -68.916 |
| Total Equity
| 1,590.236 | 2,077.963 | 1,431.849 | 716.852 | 423.942 | -179.177 | -68.916 |
| Total Liabilities & Shareholders Equity
| 1,960.09 | 2,802.088 | 1,954.268 | 918.761 | 512.071 | 191.596 | 251.566 |